An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

During a tense cross-examination on July 3, 2025, Acting Director of the Medicines Control Agency (MCA), Ensa Marena, admitted before the Banjul High Court that several drugs linked to the deaths of ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Regular mucus tends to be thin and slippery, and it is generally a constant presence on a day-to-day basis. Meanwhile, phlegm ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...

UPMC Children’s Community Pediatrics is seeing viral upper respiratory infections. WellSpan Pediatric Medicine Physicians across the Midstate are seeing insect bites and sunburn ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Mumbai’s Malvani police seized 700+ bottles of codeine cough syrup and arrested Naved Abdul Hamid Batatawala and Rizwan Waqil ...